Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study - Top-Institutions - MDSpire

Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study

  • By

  • Lun Liang

  • Liangbao Wen

  • Shixing Qin

  • Zhenqiang He

  • Jie Lu

  • Run Cui

  • Xiaobing Jiang

  • Hongrong Hu

  • Sheng Zhong

  • Chang Li

  • Chengwei Yu

  • Yuang Xie

  • Zhenning Wang

  • Hao Duan

  • Yonggao Mou

  • March 20, 2023

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Neurosurgery
    • Radiation Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Neurosurgery
    • Radiation Oncology

  • #3

    Dana-Farber Cancer Institute / Brigham and Women's Hospital
    Dana-Farber Cancer Institute / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Neuro-oncology
    • Thoracic Oncology
    • Neurosurgery
    • Medical Oncology

  • #4

    Sun Yat-sen University Cancer Center
    Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong

    Key Differentiators

    • Thoracic Oncology
    • Neurosurgery
    • Neuro-oncology

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Neuro-oncology
    • Thoracic Oncology

Original Source(s)

Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study

  • by Lun Liang, Liangbao Wen, Shixing Qin, Zhenqiang He, Jie Lu, Run Cui, Xiaobing Jiang, Hongrong Hu, Sheng Zhong, Chang Li, Chengwei Yu, Yuang Xie, Zhenning Wang, Hao Duan, Yonggao Mou

  • March 20, 2023

Related Content

Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases

Non-invasive radiogenomic mapping of the SMARCAL1-driven ferroptotic niche is associated with longitudinal MRD-negative surveillance in early-stage NSCLC

An ASCO preview: What to watch for at cancer research’s big meeting